From the Bench, Fall 2026: Virtual Cells, Talking Cells, Eating Cells, and More
In the latest edition of From the Bench, the AACR Blog explores recent innovative approaches to cancer research, including...
Tag: immunotherapy
In the latest edition of From the Bench, the AACR Blog explores recent innovative approaches to cancer research, including...
Results from a phase III trial showed that a cancer vaccine can improve outcomes for certain patients with melanoma,...
This year’s Party with a Purpose, hosted by the Friends of the AACR Foundation, will honor Robert H. Vonderheide,...
Featuring insights from Carl H. June, MD, FAACR, this post covers the ongoing challenges facing CAR T-cell therapy and...
We highlight some of the many innovations showcased at the inaugural AACR Drug Discovery and Development (AACR D3) conference,...
With seven CAR T-cell therapies approved by the U.S. Food and Drug Administration, this innovative immunotherapy has revolutionized the...
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
At AACR IO 2026, Nobel laureate Fred Ramsdell explained the research history of regulatory T cells (Tregs) and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...